US FDA grants breakthrough designation for early-stage breast cancer detection blood test developed in India by Datar Cancer Genetics

Nov 20, 2021

Mumbai (Maharashtra) [India], November 20 (ANI/PRNewswire): Datar Cancer Genetics, a leading cancer research company today announced that the US Food and Drug Administration (FDA)...

Non-Invasive Liquid Biopsy to help cancer diagnosis gets CE Certification

Mar 11, 2021

London [UK]/Mumbai (Maharashtra) [India], March 11 (ANI/PRNewswire): Datar Cancer Genetics, a global leader in non-invasive cancer diagnostics, has received Conformite Europeenne (CE) Mark for...

Dr Massimo Cristofanilli, MD Joins Datar Cancer Genetics as Strategic Advisor

Feb 11, 2025

New York [US]/ London [UK]/ Munich [Germany]/ New Delhi [India], February 11: Datar Cancer Genetics (DCG), a global leader in non-invasive cancer diagnostics, announces...

Datar Cancer Genetics Introduces Revolutionary Tumor-Agnostic + Informed Blood Test for Residual Disease Monitoring

Jan 22, 2025

London [UK]/ Munich [Germany]/ New Delhi [India], January 22: Datar Cancer Genetics (DCG) today announced the launch of Target-MRD, an advanced molecular residual disease...

Blood test that can detect breast cancer, available in India now

Jun 22, 2022

New Delhi [India], June 22 : In a first-of-its-kind, a blood test can detect breast cancer at very early stages. It has been launched...

Datar Cancer Genetics to Provide Groundbreaking Video-Enhanced Results of In-Vitro Chemotherapy Effectiveness Tests for Cancer Patients

Jan 28, 2025

New Delhi [India] / London [UK] / Munich [Germany], January 28: Datar Cancer Genetics (DCG) has launched a revolutionary video-reporting service for in-vitro chemosensitivity...